Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Net Income (2020 - 2025)

RxSight's Net Income history spans 6 years, with the latest figure at -$9.2 million for Q4 2025.

  • For Q4 2025, Net Income fell 142.63% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$38.9 million, down 79377.55%, while the annual FY2025 figure was -$38.9 million, 79377.55% down from the prior year.
  • Net Income reached -$9.2 million in Q4 2025 per RXST's latest filing, up from -$9.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $33.0 million in Q4 2021 to a low of -$17.6 million in Q1 2022.
  • Average Net Income over 5 years is -$7.7 million, with a median of -$10.8 million recorded in 2025.
  • Peak YoY movement for Net Income: plummeted 158.57% in 2022, then soared 333.88% in 2024.
  • A 5-year view of Net Income shows it stood at $33.0 million in 2021, then tumbled by 147.36% to -$15.6 million in 2022, then skyrocketed by 41.2% to -$9.2 million in 2023, then skyrocketed by 333.88% to $21.5 million in 2024, then plummeted by 142.63% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Net Income are -$9.2 million (Q4 2025), -$9.8 million (Q3 2025), and -$11.8 million (Q2 2025).